Oxford Performance Materials Completes $2 Million Financing

Oxford Performance Materials, Inc., (OPM) announced today it has completed a $2 million equity investment led by Longmeadow Capital Partners. Proceeds from the investment will be used to accelerate market development of its OXPEKK® proprietary high performance polymers.

August 26, 2004, Enfield, CT -- Oxford Performance Materials, Inc., (OPM) announced today it has completed a $2 million equity investment led by Longmeadow Capital Partners. Proceeds from the investment will be used to accelerate market development of its OXPEKK® proprietary high performance polymers.

The Series A Preferred stock investment was sponsored by Longmeadow Capital Partners LLC (Longmeadow), located in Longmeadow Massachusetts. OPMs President, Scott DeFelice said, I am very pleased OPM could attract an investor with hands on entrepreneurial experience, strategic focus and access to capital that will support OPM through the growth phase of our enterprise. These new resources will allow OPM to significantly expand market development of our OXPEKK® high performance polymers in our core medical implant, semiconductor, defense, industrial and fuel cell markets."

Founded in March 2000, OPM has rapidly become an industry leader in the ultra-high performance thermoplastic polymers market. The firm's versatile OXPEKK® polymers are currently being used in the most demanding, highly critical applications ranging from long term human medical implant devices, to critical components of the semiconductor manufacturing process to fuel cell components for the Space Shuttle. OXPEKK® delivers ultra high purity, high temperature resistance, excellent chemical resistance, biocompatibility and mechanical properties comparable to metals. OXPEKK® is a true thermoplastic which can be processed by conventional polymer processing methods. For additional information, please visit www.oxfordpm.com

Longmeadow seeks to invest in select opportunities with the potential to create uncommon value for its investors and business partners. Longmeadow Managing Partner Richard Steele said, We are convinced OPM has a unique opportunity to create a world class specialty polymer business. We are particularly impressed with the Companys technology, its vision and the exciting potential in each of its core market segments- medical implants, semiconductor, defense, industrial and fuel cells. We are committed to working with and supporting the Company to achieve its full potential."

Founded in 1993, Longmeadow is a value-added private equity firm that invests in small to mid-sized businesses with unique opportunities to create value. The firm has successfully invested in a variety of industries, as a result of its active involvement with a small number of investments and its ability to generate the capital, talent and strategy necessary for sustained growth. For additional information please visit www.longmeadowcapital.com